The correction refers to the MAR label. This press release should be with MAR label -Selected for presentation at the Chinese Urology Association’s national congress With the second independent pilot study in the East Asia region showing strong clinical performance, Prostatype Genomics is now reviewing commercialization opportunities in the region. The recent study was conducted […]
The press release concerns the MAR label and Prostatype Genomics’ review of commercialization opportunities in East Asia following a pilot study in China.
Auditors Grant Thornton Sweden AB has been the Company’s auditor since 2017. Joakim Söderin (born 1970) is since 2022 the auditor in charge. Joakim Söderin is an authorised public accountant and a member of FAR (professional institute for authorised public accountants). Grant Thornton Sweden AB’s office address is Kungsgatan 57, Box 7623, SE-103 94 Stockholm, Sweden. […]
The 2025 Annual General Meeting resolved that the nomination committee will consist of three members, appointed by each of the three largest shareholders, plus the board chairman.
Prostatype Genomics develops, manufactures, and markets the Prostatype genetic test, which assesses prostate cancer aggressiveness to reduce overtreatment risks.
Prostatype Genomics specializes in developing, manufacturing, and marketing the Prostatype genetic test, which evaluates prostate cancer aggressiveness.
The Articles of Association for Prostatype Genomics AB were adopted at the 2026 general shareholders’ meeting, with the Swedish original as the authoritative version.